azomycin has been researched along with Lymphoma in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Endo, Y; Goto-Koshino, Y; Lai, YC; Miura, N; Nakaichi, M; Setoguchi, A; Tateno, M; Tsujimoto, H; Yamazaki, H | 1 |
Abrams, DN; Kumar, P; McEwan, AJ; Postema, EJ; Riauka, TA; Richmond, DA; Wiebe, LI | 1 |
Kashino, G; Kinashi, Y; Liu, Y; Masunaga, S; Nagasawa, H; Ono, K; Sakurai, Y; Suzuki, M; Tanaka, H | 1 |
Kondo, N; Maruhashi, A; Masunaga, S; Narabayashi, M; Ono, K; Sakurai, Y; Suzuki, M; Tanaka, H | 1 |
Hirayama, R; Kondo, N; Maruhashi, A; Masunaga, S; Matsumoto, Y; Narabayashi, M; Ono, K; Sakurai, Y; Suzuki, M; Tanaka, H; Uzawa, A | 1 |
Calixto, MA; Teixeira, AR; Teixeira, ML | 1 |
Gerzer, R; Höllt, V; Jakobs, KH; Müller, OA; Stalla, GK; Stalla, J; von Werder, K | 1 |
1 trial(s) available for azomycin and Lymphoma
Article | Year |
---|---|
Initial results of hypoxia imaging using 1-alpha-D: -(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole ( 18F-FAZA).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Fluorine Radioisotopes; Glioma; Head and Neck Neoplasms; Humans; Hypoxia; Lung Neoplasms; Lymphoma; Male; Middle Aged; Neoplasms; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals; Young Adult | 2009 |
6 other study(ies) available for azomycin and Lymphoma
Article | Year |
---|---|
Hypoxia-activated prodrug TH-302 decreased survival rate of canine lymphoma cells under hypoxic condition.
Topics: Animals; Antineoplastic Agents; ATP-Binding Cassette Transporters; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Dogs; Gene Expression Regulation, Neoplastic; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Lymphoma; Nitroimidazoles; Phosphoramide Mustards; Platelet-Derived Growth Factor; Prodrugs; Up-Regulation; Vascular Endothelial Growth Factor A | 2017 |
Evaluation of the radiosensitivity of the oxygenated tumor cell fractions in quiescent cell populations within solid tumors.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Radiation; Female; Gamma Rays; Lymphoma; Mice; Mice, Inbred C57BL; Micronucleus Tests; Nitroimidazoles; Oxygen; Radiation Tolerance | 2010 |
Wortmannin efficiently suppresses the recovery from radiation-induced damage in pimonidazole-unlabeled quiescent tumor cell population.
Topics: Androstadienes; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Cell Survival; DNA Damage; Drug Interactions; Drug Synergism; Lymphoma; Mice; Mice, Inbred C57BL; Nitroimidazoles; Radiation-Sensitizing Agents; Staining and Labeling; Treatment Outcome; Wortmannin | 2013 |
Radiosensitivity of pimonidazole-unlabelled intratumour quiescent cell population to γ-rays, accelerated carbon ion beams and boron neutron capture reaction.
Topics: Animals; Boron Neutron Capture Therapy; Carbon; Cell Line, Tumor; Gamma Rays; Heavy Ion Radiotherapy; Lymphoma; Mice; Mice, Inbred C57BL; Nitroimidazoles; Radiation Tolerance; Radiation-Sensitizing Agents; Radiotherapy, High-Energy; Treatment Outcome | 2013 |
Chagas' disease: carcinogenic activity of the antitrypanosomal nitroarenes in mice.
Topics: Animals; Carcinogens; Cell Division; Chagas Disease; Female; Liver; Lymph Nodes; Lymphoma; Mice; Molecular Structure; Nifurtimox; Nitroimidazoles; Trypanocidal Agents | 1994 |
Nitroimidazole derivatives inhibit anterior pituitary cell function apparently by a direct effect on the catalytic subunit of the adenylate cyclase holoenzyme.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Adrenocorticotropic Hormone; Animals; Apoenzymes; Apoproteins; Cell Membrane; Cells, Cultured; Coenzymes; Growth Hormone; Ketoconazole; Lymphoma; Nitroimidazoles; Pituitary Gland, Anterior; Pro-Opiomelanocortin; Prolactin; Rats; RNA, Messenger | 1989 |